A detailed history of Walleye Capital LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 198,659 shares of VERA stock, worth $4.15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
198,659
Holding current value
$4.15 Million
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$24.02 - $43.22 $4.77 Million - $8.59 Million
198,659 New
198,659 $4.77 Million
Q1 2023

May 15, 2023

SELL
$5.41 - $18.3 $1.19 Million - $4.01 Million
-219,104 Reduced 95.59%
10,100 $78,000
Q4 2022

Feb 14, 2023

BUY
$15.74 - $22.19 $3.61 Million - $5.09 Million
229,204 New
229,204 $4.44 Million

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $565M
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.